# Akriveia Therapeutics, LLC — Form D

Akriveia Therapeutics, LLC of SKILLMAN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-31. The offering totals $22.5M, of which $3.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-01-31
- Form: D
- Accession: 0001676950-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $22.5M
- Amount sold: $3.0M
- Remaining: $19.5M
- Investors: 1
- Date of first sale: 2018-01-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-304462

## Issuer

- Name: Akriveia Therapeutics, LLC
- CIK: 0001676950
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 23 SOUTHERN HILLS DRIVE, SKILLMAN, NJ, 08558
- Phone: 609-560-0927

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Benjamin Auspitz | Director | Skillman, NJ |
| Thomas Beck | Director | Milwaukee, WI |
| Michael Gladstone | Director | Cambridge, MA |
| David Grayzel | Director | Cambridge, MA |
| Simon Tomlinson | Director | Skillman, NJ |
| Simon Tomlinson | Executive Officer | Skillman, NJ |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2016-06-15](https://search.stillhousedata.com/formd/0001676950-16-000001) | D | $7.5M | $4.5M |

## More

- [CIK 1676950 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1676950&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001676950-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.